Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Blogs
»
Drug Injury Watch: Extent Of Digitek Recall Remains A Mystery Ten Days Later; Patients Are Left In The Dark
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
3
Vote
Drug Injury Watch: Extent Of Digitek Recall Remains A Mystery Ten Days Later; Patients Are Left In The Dark
Posted by
tjlpa
11 days ago
(
http://www.drug-injury.com
)
View profile
Category
:
Blogs
|
Tags
:
digitek
fda
drug-safety
drug-injury
Heart Medication Sold By Mylan Was Made In Actavis Plant That Received FDA Letter About Manufacturing Problems Over A Year Ago
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
tjlpa
worldpharmanews
G00gle
Related Links
Drug Injury Watch: Digitek Digoxin Recall: Tablets May Be Double The Normal Dose
Drug Injury Watch: FDA Says It Doesn't Know How Long Defective Digitek / Digoxin Pills Were Sold
Drug Injury Watch: Recall Notice For Digitek Marketed Under Bertek Label Goes Back To March 2006
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
2
Ho-Hum--Another Direct-to-Cons...
2
Drug Injury Watch: FDA Safety ...
1
Scientists identify molecule b...
Published News
2
Drug Injury Watch: FDA Safety ...
2
Ho-Hum--Another Direct-to-Cons...
1
Scientists identify molecule b...
1
Pfiser's List of Grants and Ch...
2
Drug Injury Watch: May 2008 Up...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
astrazeneca
bayer
drug-injury
fda
glaxosmithkline
novartis
pfizer
pharma
pharmalot
vytorin
read more
↑ Grab this Headline Animator
Comments